Yonatan Malca - 01 Jan 2024 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli , Attorney-in-Fact
Issuer symbol
ENTX
Transactions as of
01 Jan 2024
Net transactions value
$0
Form type
4
Filing time
03 Jan 2024, 16:19:33 UTC
Previous filing
04 Jan 2023
Next filing
29 Aug 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTX Stock Option (right to buy) Award $0 +108,333 $0.000000 108,333 01 Jan 2024 Ordinary Shares, par value NIS 0.0000769 per share 108,333 $0.6000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2024.